Cite
HARVARD Citation
Gaggiano, C. et al. (2021). Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network. Therapeutic advances in musculoskeletal disease. p. . [Online].